Jeffrey Conforti, DPM
Foot & Ankle Surgery · Paramus, NJNPI 1760499099
Payments from drug & device makers
Across 52 payments — averaging $77.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$589
- Stryker$570
- Kerecis Limited$428
- Smith+Nephew$386
- Treace Medical Concepts, Inc.$309
- Royal Biologics, Inc.$249
- plus $1K from 12 others
What the payments were for
- Food & beverage$4,028100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 8 | $589 |
| Stryker | 9 | $570 |
| Kerecis Limited | 4 | $428 |
| Smith+Nephew | 5 | $386 |
| Treace Medical Concepts, Inc. | 5 | $309 |
| Royal Biologics, Inc. | 2 | $249 |
| Organogenesis Inc. | 2 | $221 |
| Abbott | 2 | $217 |
| Angiodynamics, Inc. | 1 | $175 |
| Paragon 28, Inc. | 2 | $130 |
| AbbVie | 1 | $122 |
| GRT US Holding, Inc. | 1 | $121 |
| Paratek Pharmaceuticals, Inc. | 1 | $120 |
| Stability Biologics, LLC | 1 | $108 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $97 |
| Integra Lifesciences Corporation | 4 | $97 |
| Boston Scientific | 1 | $63 |
| Merck | 2 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$660
- Kerecis Omega3 SurgiClose$544
- Kerecis SurgiClose$536
- Fibrinet$249
- Auryon Laser System 100-120 Vac$175
- INBONE$146
- Kerecis Omega3 GraftGuide$138
- CERAMENTBONE VOID FILLER$138
- Kerecis GraftGuide$134
- ORTHOLOC 2 LAPIFUSE$129
- CITREFIX$129
- AUGMENT INJECTABLE$129
- Lapiplasty System$128
- CryoCord$127
- Magnus$127
- MaxxCell$127
- Maxx Cell$122
- MTP Fusion Plates$122
- DALVANCE$122
- PROCLAIM$122
How this compares
$4,028 in reported general payments places this provider in the 65th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 24 | $659 |
| Terbinafine Hcl | 26 | $270 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $211 |
| Pregabalin | 12 | $104 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Paramus
- Wayne BerberianNewark$2M
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$847K
- Shane HollawellManasquan$753K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Sheldon LinNewark$253K
- Mark SolomonCedar Knolls$232K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.